$22,46
▼ $-1,98
(-8,10%)
Vol. 138K
Consenso Wall Street
9 analisti · Apr 20265
Acquisto forte
3
Compra
1
Mantieni
0
Vendi
0
Vendita forte
88,9%
Rating Compra
Grafico dei Prezzi
Titoli simili
PCRX
Pacira Biosciences Inc
P/E 51,9
$1.1B
PHAT
Phathom Pharmaceuticals Inc
$1.2B
BIOA
BIOAGE Labs Inc
$474.4M
OMER
Omeros Corp
$1.2B
RLMD
Relmada Therapeutics Inc
$354.2M
ARVN
Arvinas Inc
$761.7M
ETON
Eton Pharmaceuticals Inc
$453.5M
LXRX
Lexicon Pharmaceuticals Inc
$417.9M
ESPR
Esperion Therapeutics Inc
$884.5M
Ricavi e utili trimestrali
| Trimestre | 2024-1… |
|---|---|
| Ricavi | — |
| Utile netto | -$8.4M |
Salute finanziaria
Flusso di cassa libero
-$6.7M
Debito netto
-$102.4M
Liquidità
$106.0M
Debito totale
$3.6M
Aggiornato al Set 30, 2025
Confronto tra pari
| Ticker | Cap. mercato | P/E | P/S | ROE | Margine | Beta |
|---|---|---|---|---|---|---|
| SGP | — | — | — | — | — | — |
| PCRX | $1.1B | 51,9 | 1,6 | 2,8% | 3,0% | 0,25 |
| PHAT | $1.2B | — | 8,0 | -232,8% | -186,5% | 0,48 |
| BIOA | $474.4M | — | — | -25,1% | — | 1,59 |
| OMER | $1.2B | — | 17,1 | 107,5% | -202,0% | 2,58 |
| RLMD | $354.2M | — | — | -269,5% | — | 0,78 |
| ARVN | $761.7M | — | 2,4 | -9,8% | -18,7% | 1,87 |
| ETON | $453.5M | — | 6,4 | -27,9% | -9,5% | 1,22 |
Ultime notizie
Nessuna notizia correlata ancora